This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

UK Frand determination in Optis-Apple patent row weighs heavy on US panel

By Melissa Ritti ( May 9, 2025, 17:54 GMT | Insight) -- The implications of a UK Court of Appeal decision last week which upped, by order of magnitude, the amount Apple owes for infringing cellular standard essential patents owned by Optis was very much on the minds of a US Court of Appeals for the Federal Circuit panel this morning. Tasked with deciding whether to reinstate a Texas jury’s $506 million verdict, uphold the $300 million awarded to Optis in a damages-only retrial, or order a new trial on Apple’s infringement liability, all three judges were incredulous that neither side updated them this week with a copy of the UK judgment.Optis and Apple squared off today in the US over the outcome of two Texas trials that ultimately saw Optis win $300 million for Apple’s infringement of five 4G (LTE) cellular standard essential patents, or SEPs....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections